MX9201711A - Metodo para retardar y reducir la aparicion del virus resistente a analogos de nucleosidos, en un paciente que tiene una infeccion por vih. - Google Patents

Metodo para retardar y reducir la aparicion del virus resistente a analogos de nucleosidos, en un paciente que tiene una infeccion por vih.

Info

Publication number
MX9201711A
MX9201711A MX9201711A MX9201711A MX9201711A MX 9201711 A MX9201711 A MX 9201711A MX 9201711 A MX9201711 A MX 9201711A MX 9201711 A MX9201711 A MX 9201711A MX 9201711 A MX9201711 A MX 9201711A
Authority
MX
Mexico
Prior art keywords
delay
patient
appearance
reduce
hiv infection
Prior art date
Application number
MX9201711A
Other languages
English (en)
Spanish (es)
Inventor
William A Carter
Original Assignee
Hem Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Pharma Corp filed Critical Hem Pharma Corp
Publication of MX9201711A publication Critical patent/MX9201711A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MX9201711A 1991-04-16 1992-04-13 Metodo para retardar y reducir la aparicion del virus resistente a analogos de nucleosidos, en un paciente que tiene una infeccion por vih. MX9201711A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68620091A 1991-04-16 1991-04-16

Publications (1)

Publication Number Publication Date
MX9201711A true MX9201711A (es) 1992-10-01

Family

ID=24755338

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9201711A MX9201711A (es) 1991-04-16 1992-04-13 Metodo para retardar y reducir la aparicion del virus resistente a analogos de nucleosidos, en un paciente que tiene una infeccion por vih.

Country Status (10)

Country Link
EP (1) EP0581906A4 (pt)
JP (1) JPH06507624A (pt)
CN (1) CN1082819C (pt)
AU (1) AU671800B2 (pt)
CA (1) CA2102221A1 (pt)
IE (1) IE920873A1 (pt)
MX (1) MX9201711A (pt)
PT (1) PT100340A (pt)
WO (1) WO1992018004A1 (pt)
ZA (1) ZA922755B (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945082A (en) * 1985-08-26 1990-07-31 Hem Research, Inc. Controlled dsRNA therapy for human viral infections
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
US4820696A (en) * 1985-08-26 1989-04-11 Hem Research, Inc. Modulation of aids virus-related events by double-stranded RNAS
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases

Also Published As

Publication number Publication date
EP0581906A1 (en) 1994-02-09
JPH06507624A (ja) 1994-09-01
AU671800B2 (en) 1996-09-12
IE920873A1 (en) 1992-10-21
AU1871892A (en) 1992-11-17
ZA922755B (en) 1993-04-28
PT100340A (pt) 1993-07-30
EP0581906A4 (en) 1997-07-23
CN1082819C (zh) 2002-04-17
CA2102221A1 (en) 1992-10-17
CN1068035A (zh) 1993-01-20
WO1992018004A1 (en) 1992-10-29

Similar Documents

Publication Publication Date Title
ES2187530T3 (es) Peptidos para reducir respuestas de linfocito t ctitotoxicos al virus de la hepatitis b.
AR012614A1 (es) Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento
CA2068943A1 (en) 1,3-oxathiolanes useful in the treatment of hepatitis
CA2072573A1 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
SE9602931D0 (sv) New medicinal use
WO1993017651A3 (de) Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung
FI923357A (fi) Framstaellning av fettsyramediciner
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
EP0230574A3 (en) Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
FR2669346B1 (fr) Vaccin a poxvirus recombinant contre le virus de la rougeole.
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
DK416089A (da) Heparinfragmenter og -fraktioner med anti-hiv virkning
AU1226288A (en) Processes for the preparation of medicinal compositions, compositions obtained by these processes and use thereof for the preparation of medicines against viral hepatitis b and acquired immunodeficiency syndrome
ES2181502T3 (es) Tratamiento de la infeccion de hepatitis b con timosina alfa 1 y lamivudina.
WO1990013281A3 (en) Method of suppressing hiv infection
ES1016092Y (es) Depresor anatomico lingual desechable y esteril, para la exploracion del istmo de las fauces y la faringe.
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
FI890116A0 (fi) Icke-reverterande rna-virus.
MX9201711A (es) Metodo para retardar y reducir la aparicion del virus resistente a analogos de nucleosidos, en un paciente que tiene una infeccion por vih.
ES2046246T3 (es) Composicion terapeutica para combatir el sida.
DK720588D0 (da) Forbindelser til anvendelse ved behandling eller forebyggelse af human-immundefektvirus-(hiv)-infektion, og farmaceutiske praeparater indeholdende samme
KR900007816A (ko) 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도
ES2167536T3 (es) Vacuna dirigida contra el agente de la anemia infecciosa en pollos de engorde.
ES2160927T3 (es) Composiciones farmaceuticas que comprenden interferon alfa humano natural.
IT1211681B (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti